L
Laurence Collette
Researcher at European Organisation for Research and Treatment of Cancer
Publications - 281
Citations - 37642
Laurence Collette is an academic researcher from European Organisation for Research and Treatment of Cancer. The author has contributed to research in topics: Prostate cancer & Cancer. The author has an hindex of 78, co-authored 276 publications receiving 33811 citations. Previous affiliations of Laurence Collette include VU University Amsterdam & Université catholique de Louvain.
Papers
More filters
Journal ArticleDOI
Preoperative radiotherapy (preop RT) in rectal cancer: Impact of chemotherapy on the outcome—Long-term results of the randomized 22,921 phase III trial of EORTC.
Jean François Bosset,Gilles Calais,Laurent Mineur,Philippe Maingon,L. Radosevic-Jelic,Alain Daban,Etienne Bardet,Alexander Beny,Jean Claude Ollier,Michel Bolla,Dominique Marchal,Jean-Luc Van Laethem,Vincent Klein,Jordi Giralt,Pierre Clavere,Pascal Cellier,Laurence Collette +16 more
TL;DR: The 5-year results showed that adding CT preoperatively or postoperatively had no significant effect on overall survival (OS) nor on disease-free survival (DFS) but a divergence seemed to emerge respectively at 2 and 5 years in the postop CT group.
Journal ArticleDOI
665: Baseline PSA and PSA Doubling Time Predict the Risk of Objective Progression and Death in Patients with T0-4 N0-2 M0 Prostate Cancer on Watchful Waiting
Urs E. Studer,Laurence Collette,Peter Whelan,Walter Albrecht,Jacques Casselman,Theo M. de Reijke,Dieter Hauri,Wolfgang Loidl,Santiago Isorna,Subramanian K. Sundaram +9 more
Journal ArticleDOI
Intergroup study EORTC-1333-GUCG: A randomized multicenter phase III trial comparing enzalutamide vs. a combination of Ra223 and enzalutamide in asymptomatic or mildly symptomatic castration resistant prostate cancer (CRPC) patients metastatic to bone (PEACE III).
Bertrand F. Tombal,Yohann Loriot,Fred Saad,Raymond S. McDermott,Sandrine Marreaud,Laurence Collette,Silke Gillessen +6 more
TL;DR: There is a good rationale to combine Ra-223 to modern AR pathway inhibitors and to initiate the treatment in asymptomatic or moderately symptomatic patients.
Journal Article
Survival after peri-operative chemotherapy with folfox 4 and surgery for resectable colorectal cancer liver metastases. Final results of the eortc intergroup randomized phase III study 40983
Bernard Nordlinger,Halfdan Sorbye,Laurence Collette,M. Praet,Bengt Glimelius,Graeme J. Poston,Peter M. Schlag,Ph. Rougier,Wolf O. Bechstein,John N. Primrose,Euan Walpole,Meg Finch-Jones,Daniel Jaeck,Darius F. Mirza,Rowan W. Parks,Thomas Gruenberger +15 more
Journal ArticleDOI
The EORTC Genito-Urinary Cancers Group: 35 years of achievements and future strategy
Richard Sylvester,Laurence Collette,Axel Bex,Noel W. Clarke,Cora N. Sternberg,Bertrand Tombal +5 more
TL;DR: The GU Group's primary aim will be to focus on clinical trials that investigate strategic therapeutic questions and which have the potential to change medical practice and improve the authors' understanding of urologic malignancies.